Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Talazoparib by Pfizer for Breast Cancer: Likelihood of Approval
Talazoparib is under clinical development by Pfizer and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...
Data Insights
Talazoparib by Pfizer for Bladder Cancer: Likelihood of Approval
Talazoparib is under clinical development by Pfizer and currently in Phase I for Bladder Cancer. According to GlobalData, Phase I...